BrainStorm Cell Therapeutics raises $4.0M in registered direct offering and warrants

BRAINSTORM CELL THERAPEUTICS INC.

Gross proceeds ~$4.0M from sale of 11.1M shares or pre-funded warrants at $0.36/share.
Private placement of warrants to buy 16.7M shares at $0.3912, exercisable after 6 months, 5-year term.
Existing warrants for 4.05M shares amended: exercise price cut to $0.3912, expiry extended to 2029.
Offering expected June 28, 2024; Maxim Group as placement agent.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.